Bone Biologics Corp Annual Nonoperating Income (Expense) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Bone Biologics Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from 2013 to 2023.
  • Bone Biologics Corp Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $10K, a 93.8% decline year-over-year.
  • Bone Biologics Corp Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$316K.
  • Bone Biologics Corp annual Nonoperating Income (Expense) for 2023 was $480K, a 78% decline from 2022.
  • Bone Biologics Corp annual Nonoperating Income (Expense) for 2022 was $2.18M.
  • Bone Biologics Corp annual Nonoperating Income (Expense) for 2021 was -$508K, a 49.1% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $480K -$1.7M -78% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-21
2022 $2.18M +$2.69M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-21
2021 -$508K +$490K +49.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$998K -$22.3K -2.29% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 -$976K +$662K +40.4% Jan 1, 2019 Dec 31, 2019 10-K 2020-03-30
2018 -$1.64M +$2.79M +63% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 -$4.42M +$1.04M +19% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 -$5.46M -$3.59M -192% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 -$1.87M -$460K -32.6% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 -$1.41M -$1M -245% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-28
2013 -$409K Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.